|
|
|
|
Contains information about title and source of a journal
| Title: |
A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors. |
| Source: |
Proceedings of the National Academy of Sciences of the United States of America
[0027-8424]
Scott
yr:2007
vol:104
iss:10
pg:4071
|
|
|
|
Contains list of services for current record
|
|
|
|
|
© 2009 SFX by Ex Libris Inc.
CrossRef Enabled
|